Healthy men to test copycat cancer drug in early safety study
NCT ID NCT07299955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new experimental drug called Bmab3000 against an approved drug, Herceptin Hylecta, in 150 healthy male volunteers. The goal is to see how the body absorbs and processes the new drug and whether it causes any side effects. Participants receive a single injection under the skin and are monitored for several months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGChristchurch, Main Building: 264 Antigua Street,, New Zealand
More trials for these conditions
Other studies related to the condition(s) this trial covers.